anti-MMP4 (MMP4) Antikörper

Auf finden Sie aktuell 2 Matrix Metalloproteinase 4 (MMP4) Antikörper von 1 unterschiedlichen Herstellern. Zusätzlich bieten wir Ihnen MMP4 Kits (12) und viele weitere Produktgruppen zu diesem Protein an. Insgesamt sind aktuell 14 MMP4 Produkte verfügbar.
4F.1, CBTF, cbtf122, DRBF, DRBP76, ilf3, ilf3-A, MBII-26, MMP4, MPHOSPH4, MPP4, NF-AT-90, NF90, NF90a, NF90b, NF110, NF110b, NFAR, NFAR-1, NFAR2, TCP80, TCP110, ubp3, ubp4, wu:fb37d07, wu:fb94b02, xilf3, zgc:77030
Alle Antikörper anzeigen Gen GeneID UniProt
Anti-Maus MMP4 MMP4 16201 Q9Z1X4
Anti-Ratte MMP4 MMP4 84472 Q9JIL3
MMP4 3609 Q12906

Meistgesuchte Reaktivitäten zu anti-MMP4 (MMP4) Antikörper

anti-Human MMP4 Antikörper:

Alle verfügbaren anti-MMP4 Antikörper

Sie gelangen zu unserer vorgefilterten Suche.

Weitere Antikörper gegen MMP4 Interaktionspartner

Mouse (Murine) Matrix Metalloproteinase 4 (MMP4) Interaktionspartner

  1. Data support a model in which NF45 (zeige ILF2 Antikörper), NF90, and NF110 operate in feedback loops that enable them, through both overlapping and independent targets, to help balance the push and pull of pluripotency and differentiation cues.

  2. Reduction in the expression of YBX1 (zeige YBX1 Antikörper) and ILF3 controls the expression of pluripotency-related genes in ESCs (zeige NR2E3 Antikörper), suggesting their roles in further regulation of the pluripotent state of ESCs (zeige NR2E3 Antikörper).

  3. NF90-NF45 (zeige ILF2 Antikörper) complex induces centronuclear myopathy through increased dynamin 2 (zeige DNM2 Antikörper) expression by an NF90-NF45 (zeige ILF2 Antikörper)-induced reduction of miR (zeige MLXIP Antikörper)-133a expression in vivo.

  4. This work allows to establish a link between Ilf3 and NF90 functions, as RNA binding proteins, and their interacting partners implicated in these functions.

  5. High expression of nuclear factor 90 leads to mitochondrial degradation in skeletal and cardiac muscles through a negative regulation of ribosomes via interaction with ribosomal factors.

  6. cloning of human NF90

  7. characterization of NFAR-1 and NFAR-2 splice forms in human sample

  8. NF90 regulates cell cycle exit and terminal myogenic differentiation by direct binding to the 3'-untranslated region of MyoD (zeige MYOD1 Antikörper) and p21WAF1/CIP1 mRNAs

  9. ADAR1 (zeige ADAR Antikörper) has the potential both to change information content through editing of mRNA and to regulate gene expression through interacting with NF90

  10. NF90 regulates inducible IL-2 (zeige IL2 Antikörper) gene expression in T cells.

Xenopus laevis Matrix Metalloproteinase 4 (MMP4) Interaktionspartner

  1. Studies suggest a two-component model for the binding of CBTF with gata2 (zeige GATA2 Antikörper) promoter, requiring both a CCAAT and A-form DNA, and the double stranded RNA binding domains (dsRBDs) of CBTF component Xilf3 must be active for both binding to the promoter.

Human Matrix Metalloproteinase 4 (MMP4) Interaktionspartner

  1. Reprot a coordinated regulation of circRNA biogenesis and function by NF90/NF110 in viral infection.

  2. The NF90 regulates PARP1 (zeige PARP1 Antikörper) mRNA stability in hepatocellular carcinoma cells, and NF90 is a potential target to inhibit PARP1 (zeige PARP1 Antikörper) activity.

  3. Variants in ILF3 gene is associated with thrombosis.

  4. these data establish miR (zeige MLXIP Antikörper)-590-5p as an anti-onco-miR (zeige MLXIP Antikörper) that inhibits colorectal cancer angiogenesis and metastasis through a new mechanism involving NF90/VEGFA (zeige VEGFA Antikörper) signaling axis.

  5. The data suggest that features of both the N- and C-termini of NF90 participate in the heterodimerization with NF45 (zeige ILF2 Antikörper) and that the formation of NF90-NF45 (zeige ILF2 Antikörper) changes the conformation of NF90's RNA-binding motifs to a status in which the co-operative interplay of the RNA-binding motifs is optimal.

  6. NF90-NF45 (zeige ILF2 Antikörper) stimulates an elevation of EGF receptor (zeige EGFR Antikörper) levels via the suppression of miR-7 (zeige LILRB1 Antikörper) biogenesis, resulting in the promotion of cell proliferation in Hepatocellular Carcinoma.

  7. NF90 exerts its antiviral activity by antagonizing the inhibitory role of NS1 (zeige PTPN11 Antikörper) on PKR (zeige PKLR Antikörper) phosphorylation

  8. Deletion of the RNA binding domains of NF45 (zeige ILF2 Antikörper) and NF90 diminished the enhancement of HIV infection and gene expression.

  9. These data suggest that, like ADAR2 (zeige ADARB1 Antikörper), underlying sequences in dsRNA may influence how NF90 recognizes its target RNAs

  10. The NF90 C-terminus is involved in conformational changes in the protein after RNA binding.

MMP4 Antigen-Profil

Beschreibung des Gens

This gene encodes a double-stranded RNA (dsRNA) binding protein that complexes with other proteins, dsRNAs, small noncoding RNAs, and mRNAs to regulate gene expression and stabilize mRNAs. This protein was first discovered to be a subunit of the nuclear factor of activated T-cells (NFAT)\; a transcription factor required for T-cell expression of interleukin 2. NFAT is a heterodimer of 45 kDa and 90 kDa proteins, the larger of which is the product of this gene. These proteins have been shown to affect the redistribution of nuclear mRNA to the cytoplasm. Knockdown of NF45 or NF90 protein retards cell growth\; possibly by inhibition of mRNA stabilization. In contrast, an isoform (NF110) of this gene that is predominantly restricted to the nucleus has only minor effects on cell growth when its levels are reduced. Alternative splicing results in multiple transcript variants encoding distinct isoforms.

Alternative names and synonyms associated with MMP4

  • interleukin enhancer binding factor 3 (Ilf3) Antikörper
  • interleukin enhancer binding factor 3, 90kDa (ilf3-b) Antikörper
  • interleukin enhancer binding factor 3, 90kDa (ILF3) Antikörper
  • interleukin enhancer binding factor 3b (ilf3b) Antikörper
  • 4F.1 Antikörper
  • CBTF Antikörper
  • cbtf122 Antikörper
  • DRBF Antikörper
  • DRBP76 Antikörper
  • ilf3 Antikörper
  • ilf3-A Antikörper
  • MBII-26 Antikörper
  • MMP4 Antikörper
  • MPHOSPH4 Antikörper
  • MPP4 Antikörper
  • NF-AT-90 Antikörper
  • NF90 Antikörper
  • NF90a Antikörper
  • NF90b Antikörper
  • NF110 Antikörper
  • NF110b Antikörper
  • NFAR Antikörper
  • NFAR-1 Antikörper
  • NFAR2 Antikörper
  • TCP80 Antikörper
  • TCP110 Antikörper
  • ubp3 Antikörper
  • ubp4 Antikörper
  • wu:fb37d07 Antikörper
  • wu:fb94b02 Antikörper
  • xilf3 Antikörper
  • zgc:77030 Antikörper

Bezeichner auf Proteinebene für MMP4

M phase phosphoprotein 4 , interleukin enhancer-binding factor 3 , nuclear factor 90 , nuclear factor associated with dsRNA , CCAAT box transcription factor p122 subunit , CCAAT box transcription factor subunit , Double-stranded RNA-binding protein 4F.1 , dsRNA-binding protein 4F.1 , interleukin enhancer-binding factor 3-A , M-phase phosphoprotein 4 , double-stranded RNA-binding protein, 76 kD , dsRNA binding protein NFAR-2/MPP4 , nuclear factor of activated T-cells 90 kDa , nuclear factor of activated T-cells, 90 kD , translational control protein 80 , interleukin enhancer binding factor 3, 90kDa , interleukin enhancer-binding factor 3 homolog

16201 Mus musculus
84472 Rattus norvegicus
399197 Xenopus laevis
3609 Homo sapiens
484950 Canis lupus familiaris
614936 Bos taurus
321868 Danio rerio
Ausgewählte Anbieter für anti-MMP4 (MMP4) Antikörper
Haben Sie etwas anderes gesucht?